logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9624182 B1

PDFFull Text
Date of Patent:
Apr. 18, 2017

Filed:

Jun. 30, 2015

Compounds as lysophosphatidic acid receptor antagonists

Applicant:

Amira Pharmaceuticals, Inc., Princeton, NJ (US);

Inventors:

Thomas J. Seiders, San Diego, CA (US);

Lucy Zhao, San Diego, CA (US);

Jeannie Arruda, San Diego, CA (US);

Bowei Wang, Westfield, NJ (US);

Brian Andrew Stearns, Encinitas, CA (US);

Yen Pham Truong, San Diego, CA (US);

Jill Melissa Scott, San Diego, CA (US);

John Howard Hutchinson, San Diego, CA (US);

Ryan Clark, San Diego, CA (US);

Heather Renee Coate, San Diego, CA (US);

Nicholas Simon Stock, San Diego, CA (US);

Deborah Volkots, New York, NY (US);

Assignee:

AMIRA PHARMACEUTICALS, INC., Princeton, NJ (US);

Attorney:

Hoffmann & Baron, LLP

Primary Examiner:

Matthew Coughlin

Int. Cl.
CPC ...
C07D 417/12 (2006.01); C07D 413/06 (2006.01); C07D 413/12 (2006.01); C07D 495/04 (2006.01); C07D 261/08 (2006.01); C07D 261/14 (2006.01); A61K 31/519 (2006.01); A61K 31/4725 (2006.01); A61K 31/4439 (2006.01); A61K 31/427 (2006.01); A61K 31/4709 (2006.01); C07D 261/18 (2006.01); C07D 405/12 (2006.01); A61K 31/42 (2006.01); A61K 31/422 (2006.01);
U.S. Cl.
CPC ...
C07D 261/08 (2013.01); A61K 31/42 (2013.01); A61K 31/422 (2013.01); A61K 31/427 (2013.01); A61K 31/4439 (2013.01); A61K 31/4709 (2013.01); A61K 31/4725 (2013.01); A61K 31/519 (2013.01); C07D 261/14 (2013.01); C07D 261/18 (2013.01); C07D 405/12 (2013.01); C07D 413/06 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 495/04 (2013.01);
Abstract

Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.

Find Patent Forward Citations

Loading…